Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

In patients with cardiogenic shock (CS), a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory support. Given the high ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes ...

In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes ...

“We believe that the NCE exclusivity strategy is an attractive approach if istaroxime receives FDA approval in cardiogenic shock,” said Jed Latkin, Chief Executive Officer of Windtree.

In patients with heart failure, cannabis use disorder was linked to higher odds of MI, cardiogenic shock and arrhythmias. Mortality and respiratory failure were lower among cannabis users.